D349-0145 Screening compound: N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)phenoxy]acetamide

D349-0145 Screening compound: N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)phenoxy]acetamide
D349-0145 Screening compound: N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)phenoxy]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D349-0145
N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)phenoxy]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D349-0145

Molecular Formula

C19H15N5O3S (C19 H15 N5 O3 S)

Compound Name

N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)phenoxy]acetamide

IUPAC name

N-(5-methyl-134-thiadiazol-2-yl)-2-[2-(3-phenyl-124-oxadiazol-5-yl)phenoxy]acetamide

SMILES

Cc1nnc(NC(COc(cccc2)c2-c2nc(-c3ccccc3)no2)=O)s1

InChI

InChI=1S/C19H15N5O3S/c1-12-22-23-19(28-12)20-16(25)11-26-15-10-6-5-9-14(15)18-21-17(24-27-18)13-7-3-2-4-8-13/h2-10H,11H2,1H3,(H,20,23,25)

InChI Key

BTWFRLWAVYIEAD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14821266

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

393.43

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.711

Distribution Coefficient, logD

3.657

Water Solubility, LogSw

-4.04

Polar Surface Area

85.459

Acid Dissociation Constant (pKa)

8.28

Base Dissociation Constant (pKb)

-2.64

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

10.50

D349-0145 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with D349-0145 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D349-0145?
Check Price and Availability of D349-0145, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D349-0145 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D349-0145
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D349-0145
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D349-0145 available by request